InvestorsHub Logo
Followers 22
Posts 713
Boards Moderated 0
Alias Born 02/18/2014

Re: cottonmather post# 92671

Wednesday, 10/22/2014 9:39:44 PM

Wednesday, October 22, 2014 9:39:44 PM

Post# of 113924
Out of curiosity, why would be given an account? Are you some kind of financial advisor, detective, accountant or attorney? Can we see? Have you seen this information yet? Do you think it's worthwhile? Could you please explain? Thank you.


It seems like the machine was given to NMU labs in March of 2014.

http://www.micro-imaging.com/content/micro-imaging-technology-enters-phase-1-its-collaboration-northern-michigan-university

MIT 1000 has a list of identifications:

MIT 1000 has been certified by the AOAC for identification of Listeria spp. The Company recently announced that it had also added Staphylococcus (Staph) and Salmonella enterica serotype Choleraesuis (S. Choleraesuis) to its catalog of identifiers. It is continuing development of, a series of Salmonella Identifiers including Salmonella spp, S. Heidelberg, S. Enteritidis and S. Typhimurium.

This article just a few months after in July of 2014.

http://www.micro-imaging.com/content/mit-and-n-michigan-university-investigate-mit-1000-enhancement-give-more-rapid-pathogen-test

So the problem isn't if the machine works, it's really just isolating samples of the pathogen quicker than the conventional agar plate based method.

“It has been shown that rapid identification of bacterial pathogens has the potential to improve successful patient outcomes,” said Dr. Sharp. “However many of the current agar plate based identification methods require 16-24 hours of growth before identifications can be made,” he continued. “To decrease the time for organism identification, the Sharp lab at NMU will be working in collaboration with MIT to develop a method to capture S. aureus bacteria directly from a specimen. Using the MIT 1000, this would decrease the total time for S. aureus identification to 4 to 5 hours. Our goal is to reduce the time from specimen to pathogen identification resulting in the ability to quickly implement proper antimicrobial therapy to patients.”

Why wouldn't they release it as it? Because conventional methods already exists. This machine has more applications than the conventional method is limited to. Being that is recognizes the shape of the pathogen, it doesn't need to cultivate a specimen first to test it. I'm confident that this company will be picked up by a monster company like 3M just for its innovation.

http://news.3m.com/press-release/product-and-brand/3m-molecular-detection-assay-listeria-monocytogenes-earns-aoac-ptm-a